News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug
Clearmind Medicine
PsyBio Therapeutics Announces Participation in Upcoming Investor Conferences in September 2021
PsyBio Therapeutics
Algernon Pharmaceuticals Announces Plans for a Phase 2 Ifenprodil Chronic Cough Study in the U.S.
Algernon Pharmaceuticals
Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
Enveric Biosciences
PsyBio Therapeutics Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund
PsyBio Therapeutics
Tryp Therapeutics to Present at Oppenheimer Fall Healthcare Summit
Tryp Therapeutics
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
NeonMind Biosciences Inc.
MINDCURE Joins Digital Therapeutics Alliance to Drive Innovation in the Mental Health Industry
MINDCURE
Novamind to Present at Life Sciences Investor Forum
Novamind Inc.
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
Lobe Sciences
Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment
Nova Mentis Life Science
Dr. Elizabeth Nielson | Co-Founder and Lead Trainer, Fluence
Tryp Therapeutics
Fluence
Ketamine One Engages Psychology & Counselling Services Group for IRP Health PCSG to Provide Psychology, Therapy, Dietary and Other Mental Health Services for the Wholly-Owned Ketamine One Subsidiary
Wellbeing Digital Sciences
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.